The global antacid market was valued at USD 7.02 Billion in 2024, driven by the rising prevalence of gastroesophageal reflux disease and other acid-related disorders across the globe. The market is anticipated to grow at a CAGR of 3.20% during the forecast period of 2025-2034, with the values likely to reach USD 9.62 Billion by 2034.
Other key players in the market include Sanofi, WellSpring Pharmaceutical Corporation, Advance Pharmaceutical Inc., Reckitt Benckiser Group PLC, Teva Pharmaceuticals Industries Ltd., and Lupin.
This product will be delivered within 3-5 business days.
Antacid Market Overview
Antacids are commonly utilized medications that counteract excessive stomach acid, offering relief from heartburn, indigestion, and acid reflux. These are accessible without a prescription in different forms like tablets and liquids, providing rapid and effective relief from symptoms. The market is driven by advancements in formulations, changing consumer health trends, and heightened awareness of digestive wellness. The increasing occurrence of acid-related issues, combined with progress in medical research and regulatory backing, fuels the ongoing expansion of the antacids market, improving the quality of life for numerous individuals.Antacid Market Growth Drivers
Rising Prevalence of Gastroesophageal Reflux Disease To Boost Market Growth
The growing prevalence of gastroesophageal reflux disease, affecting around 30% of individuals in Western societies, significantly contributes to the expansion of the global antacid market. With gastroesophageal reflux disease being one of the most common disorders in primary care, the demand for effective antacid medications has surged. The increasing incidence of gastroesophageal reflux disease-related symptoms such as heartburn and regurgitation, alongside complications like esophageal injury, drives both preventive and symptomatic treatments, fueling market growth.Antacid Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Rising Demand for Over-the-Counter Antacids
The market is witnessing a substantial increase in the demand for over-the-counter products. Consumers are progressively choosing over-the-counter antacids to handle typical symptoms of acid reflux and heartburn. The increasing inclination towards self-medication is propelling the growth of over-the-counter antacids in both advanced and developing markets.Shift Towards Natural and Herbal Antacids
The market is witnessing a noticeable shift towards natural and herbal antacid formulations. With rising health consciousness, consumers are seeking alternatives to synthetic drugs, driving demand for antacids that incorporate organic ingredients such as ginger, chamomile, or licorice root. This trend highlights a growing preference for products that align with holistic health and wellness trends, offering gentle yet effective relief from acidity without chemical additives.Integrating New Delivery Systems
The market is transforming with the incorporation of innovative delivery methods, like chewable tablets. These advancements meet consumer desires for simplicity and user-friendliness. Chewable forms offer quicker relief and enhanced portability, attracting people especially those in need of on-the-move options. The movement towards more accessible and creative product designs is facilitating market expansion, broadening the consumer audience for antacid items.Increasing Awareness About Digestive Health
There is a significant increase in awareness regarding digestive health. There is a rising number of consumers focusing on their gut health and understanding the significance of addressing issues such as acid reflux and indigestion, which will increase the need for antacids. Moreover, health initiatives and educational campaigns are enhancing consumer awareness, encouraging a move towards preventive care, and driving up sales of antacid products as part of daily wellness practices.Antacid Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:Market Breakup by Dosage Form
- Tablet
- Capsule
- Suspension
- Others
Market Breakup by Application
- Gastroesophageal Reflux Disease
- Heartburn
- Indigestion
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Antacid Market Share
Segmentation Based on Distribution Channel to Witness Substantial Growth
The distribution channel segment is divided into hospital pharmacies, retail pharmacies, and others. Retail pharmacies are anticipated to dominate the market share throughout the forecast period. Their ease of use, convenient locations, long operating hours, and rapid services contribute to their increasing popularity. Retail pharmacies provide a variety of medications, effective order processing systems, and tailored consultations with pharmacists, improving the overall customer experience. These elements play a crucial role in their market leadership, establishing retail pharmacies as a favored option for customers.Antacid Market Analysis by Region
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market share because of a significant prevalence of gastrointestinal issues such as acid reflux and GERD, attributed to stress, unhealthy eating habits, and obesity. These lifestyle patterns drive the need for antacids as a quick way to relieve symptoms. On the other hand, the Asia Pacific region is projected to witness the fastest growth, as urbanization, shifting diets, heightened stress, and improved healthcare access augment the need for antacids, especially with the growing middle class and better affordability of over-the-counter products.Leading Players in the Antacid Market
The key features of the market report comprise patent analysis, clinical trial analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:Bayer AG
Bayer AG, a prominent global company in pharmaceuticals and biotechnology, boosted its presence in the antacid market through well-known brands such as Rennie and Alka-Seltzer. Alka-Seltzer is widely recognized for relieving digestive issues and associated pain.Haleon plc
Haleon plc, a prominent British multinational consumer healthcare firm located in Weybridge, England, is a major player in the global antacid market. Through reliable brands such as Eno and Tums, Haleon meets the increasing consumer demand for efficient digestive health solutions, promoting market growth via innovation and a robust global footprint.Sun Pharmaceutical Industries Limited
Sun Pharma, a global leader in generic medications, propels market expansion through its vast product development and manufacturing expertise in complex formulations, active pharmaceutical ingredients, and over-the-counter offerings. Its cutting-edge digestive care products, such as pepmelt mouth-melt granules, pepfiz effervescent tablets, and pepfiz antacid powder, have broadened its reach in the global antacid market, addressing various consumer needs.Procter & Gamble
Procter & Gamble, a global healthcare leader, drives market growth through innovative products and strategic collaborations. A key player in the antacid market with its Rolaids brand, P&G expanded its reach in March 2024 by partnering with Lil' Drug Store Products to target heartburn sufferers. P&G's tactical investments in advertising, product improvements, and distribution strengthen Rolaids' competitive stance.Other key players in the market include Sanofi, WellSpring Pharmaceutical Corporation, Advance Pharmaceutical Inc., Reckitt Benckiser Group PLC, Teva Pharmaceuticals Industries Ltd., and Lupin.
Key Questions Answered in the Antacid Market Report
- What was the antacid market value in 2024?
- What is the antacid market forecast outlook for 2025-2034?
- What are the regional markets covered in the report?
- What is the market segmentation based on dosage form?
- What is the market segmentation based on application?
- What is the market breakup based on the distribution channel?
- What major factors aid the demand for the antacid market?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the antacid market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Global Antacid Market Overview
4 Vendor Positioning Analysis
5 Global Antacid Market Landscape*
6 Global Antacid Market Dynamics
7 Global Antacid Market Segmentation (218-2034)
8 North America Antacid Market (218-2034)
9 Europe Antacid Market (218-2034)
10 Asia Pacific Antacid Market (218-2034)
11 Latin America Antacid Market (218-2034)
12 Middle East and Africa Antacid Market (218-2034)
13 Patent Analysis
14 Clinical Trials Analysis
15 Grants Analysis
16 Funding and Investment Analysis
17 Strategic Initiatives
18 Supplier Landscape
19 Global Antacid Market - Distribution Model (Additional Insight)
Companies Mentioned
- Bayer AG
- Haleon plc
- Sun Pharmaceutical Industries Limited
- Procter & Gamble
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 400 |
Published | June 2025 |
Forecast Period | 2025 - 2034 |
Estimated Market Value ( USD | $ 7.02 Billion |
Forecasted Market Value ( USD | $ 9.62 Billion |
Compound Annual Growth Rate | 3.2% |
Regions Covered | Global |
No. of Companies Mentioned | 4 |